[1] 张珂,雷慧,陈曦,等.血小板生成素受体激动剂治疗免疫性血小板减少症的新药研发进展[J].中国新药杂志,2017,26(20):2380-2385. [2] 魏红霞,李陈广,梁译丹,等.二甲双胍增强LPS激活的腹腔巨噬细胞在ATP刺激下的炎症小体活化[J].中国药理学通报,2017,33(4):474-479. [3] Chen L,Liu Z W,Liu T M,et al.Neonatal alloimmune thrombocytopenia caused by anti-HPA antibodies in pregnant Chinese women:a study protocol for a multicentre,prospective cohort trial[J].BMC Pregnancy Childbirth,2017,17(1):281. [4] 颜廷宇,李鑫,丁镌,等.黑龙江省汉族人群血小板抗原1~17系统基因多态性研究[J].临床输血与检验,2017,19(6):623-627. [5] 中华医学会血液分会血栓与止血学组.成人原发免疫性血小板减少症诊治的中国专家共识(修订版)[J].中华血液学杂志,2011,32(3):214-216. [6] 陈语嫣,龚祖康,林文珍.中国地区汉族人类血小板抗原基因多态性研究[J].基因组学与应用生物学,2017,36(2):433-444. [7] 杨聪聪, 刘玉峰, 魏林林,等. 人类血小板抗体检测在治疗儿童免疫性血小板减少症中的意义[J]. 中华实用儿科临床杂志, 2018, 33(3):213-216. [8] 唐利娟,周晓恒,宾琼,等.人类血小板特异性抗原及其与特发性血小板减少性紫癜相关性研究进展[J].中国输血杂志,2016,29(3):326-329. [7] Hopkins M,Lucas G,Calvert A,et al.Human platelet antigen (HPA)-specific immunoglobulin M antibodies in neonatal alloimmune thrombocytopenia can inhibit the binding of HPA-specific immunoglobulin G antibodies[J].Transfusion,2017,57(5):1267-1271. [10] Refsum E,Meinke S,Gryfelt G,et al.Adding to the complexity of fetal and neonatal alloimmune thrombocytopenia:Reduced fibrinogen binding in the presence of anti-HPA-1a antibody and hypo-responsive neonatal platelets[J].Thromb Res,2018,162:69-76. [11] 孙学兰,杨志美,张婧婧,等.豫北地区汉族无偿献血者血小板特异性抗原多态性研究[J].中国实验血液学杂志,2016,24(2):602-606. [12] 车进,王晓宁,麻静敏,等.北京地区汉族献血人群血小板HPA1-17基因多态性的研究[J].中国输血杂志,2018,31(4):401-405. [13] Carmo J C D,Klippel P S,Cordeiro S D C,et al.Molecular typing of human platelet antigens in immune thrombocytopenia patients in northern Brazil[J].Rev Bras Hematol Hemoter,2017,39(2):122-126. [14] 唐利娟,罗建明,黄小花,等.儿童慢性特发性血小板减少性紫癜与HPA基因多态性的相关性研究[J].中国输血杂志,2014,27(12):1309-1312. |